Navigation Links
The MedZilla Report: Febraury 2009 Employment Outlook for Biotech/Pharma/Health
Date:3/30/2009

After the flood of layoffs in health care in January, the industry seems to have taken a deep breath and a step back, getting back on track and creating 27,000 new jobs. Health care job cuts that were announced were mostly due to the overall economic difficulty facing the United States.

(Vocus) March 30, 2009 -- While it would be irresponsible to say the worst is past for health care, it does seem as though the industry took a deep breath and a step back in February, getting back on track after January's sweeping job cuts. About 27,000 new jobs were created in health care in February -- more than 8,000 more than were created in January -- which is more in line with 2008's average monthly job increases in the 30,000 range.


   
"For the most part, health care job cuts have come as a result of increased expenses due to the current economic situation," said Michele Hopps, director of marketing for MedZilla.com, the internet's leading site for health care, biotechnology, and pharmaceutical jobs. "The bigger hit this month unfortunately came from biotech and pharmaceuticals, which have both seen difficulties over the past 18 months." While most of those companies announced layoffs in conjunction with reorganizations, strategic shifts, and other cost-cutting measures, some, such as Trubion Pharmaceuticals, said they are eliminating positions "in the face of continuing uncertainty in the capital markets and the global economy." (Puget Sound Business Journal, February 25, 2009) Hopps said that these companies often see difficulty due to the need to specialize. "They develop drugs that might fail in clinical trials or the regulatory phase, and that's a lot of money gone toward something that won't show a return on the investment."
   
Though many health systems -- including an increasing number in Canada, primarily i
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health
2. The MedZilla Report: October 2008 Employment Outlook for Biotech/Pharma/Health
3. PharmSource and BioProcess Technology Consultants Announce Publication of New Market Report: Cell Culture Manufacturing Capacity: Trends and Outlook through 2013
4. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
5. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
6. Rabobank Releases Annual North American Food & Agribusiness Outlook
7. ViroPharma Provides 2008 Outlook
8. Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook
9. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
10. Gerresheimer: Record Year in 2007 and Positive Outlook for 2008
11. Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The MedZilla Report: Febraury 2009 Employment Outlook for Biotech/Pharma/Health
(Date:4/16/2015)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" ... with G-treeBNT (ReGenTree LLC) has retained Ora, Inc. ... the orphan disorder, neurotrophic keratopathy (NK), and a ... (DES) in the U.S.  Both trials will be ... Each of these eye disorders was being targeted ...
(Date:4/16/2015)... PHOENIX, AZ (PRWEB) April 16, 2015 ... and makes it easier for research institutions to learn ... collect clinical data. , The timing is ideal since ... on Tuesday. Research Kit is an open-source framework for ... 9. It provides a way for researchers to collect ...
(Date:4/16/2015)... 2015 Avelas Biosciences, an in vivo ... announced today that it has initiated a Phase 1b ... women with primary, non-recurrent breast cancer undergoing surgery. In ... addition of Steven Chen , M.D., as vice ... dose escalation study will enroll up to 39 women ...
(Date:4/16/2015)... and MENLO PARK, Calif. , April ... DMPI) (DelMar and the Company), a biopharmaceutical company focused ... orphan drug indications, today announced that the Mayo ... clinical trial site for the ongoing, multicenter Phase I/II ... (GBM), the most common and deadly form of human ...
Breaking Biology Technology:RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5Infographic Illustrates Potential for Research Kit to Impact Clinical Research 2Infographic Illustrates Potential for Research Kit to Impact Clinical Research 3Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 2DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 3DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 4DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 5
... in Janesville last week as General Motors announced it will ... a decision that will keep high-wage manufacturing jobs in southern ... in the Janesville line means the plant will stay open ... whether the plants total of 3,900 jobs will grow or ...
... of North Prairie, Wisconsin, has signed a contract with ... new software is fully integrated with the rest of ... chain management and financial applications, which the company implemented ... cases used primarily by grocery, convenience, and drug store ...
... Information Systems employees will be participating for the ... management students at Blackhawk Technical College , located ... a comprehensive experience for students as they research a ... technology business solutions to local businesses. , ,As ...
Cached Biology Technology:GM Choice is Great News, But Wisconsins Economy Must Keep on Truckin to Prosper in a New Era 2Zero Zone Adds Sales and Marketing Automation Tools 2
(Date:3/19/2015)... , March 19, 2015  NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces its ... a news clip that aired this week on ... . In a segment "The Next Great Thing", ... ,a new way to pay, and ,a really big breakthrough ...
(Date:3/17/2015)... Minn. , March 17, 2015 ... technology company specializing in clinical study management systems, ... be in attendance at ARENA,s Outsourcing in Clinical ... NC.  This event provides an excellent forum for ... easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical technology ...
(Date:3/17/2015)... YORK , March 17, 2015  MecklerMedia ... the largest exhibition for service robots ever held ... RoboUniverse takes place on May 11-13, 2015 at ... and exhibitors for the event include: Acorn Product ... Control; EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
... "smart village" built in Malaysia provides a potential ... sustainable environment, say international experts meeting in California,s ... built north-east of Kuala Lumpur, consists of 100 ... and a creative, closed-loop agricultural system designed to ...
... Orleans, LA Research conducted by Jesus Lovera, MD, Assistant ... and colleagues has shown that stress management treatment significantly reduced ... sclerosis (MS) over the course of treatment. These lesions are ... The work is published ahead of print and is now ...
... determine much about you, but environment can have a strong ... can last a lifetime. In a study published online ... for the first time shown that the environment experienced in ... to DNA we are born with, that could have implications ...
Cached Biology News:Pioneering self-contained 'smart village' offers world model for rural poverty relief 2Pioneering self-contained 'smart village' offers world model for rural poverty relief 3Pioneering self-contained 'smart village' offers world model for rural poverty relief 4LSUHSC research finds treating stress prevented new MS brain lesions 2Differences between human twins at birth highlight importance of intrauterine environment 2
The Varian 4000 GC/MS system offers three easily switchable ionization configurations: internal ionization (II), external ionization (EI) or hybrid chemical ionization (CI)...
GeneRacer is an advanced RACE (rapid amplification of cDNA ends) technique that improves the efficiency of amplifying full-length 5' and 3' cDNA ends. With the GeneRacer Kit you can:...
... Mouse monoclonal [APS 26] to Presenilin ... an inherited form of the disease carry ... or the amyloid precursor protein (APP). These ... the longer form of amyloid-beta (main component ...
One-step, microplate or cuvet, colorimetric, linear detection range 6 mg/dL to 100mg/dL. Procedure: 15 min....
Biology Products: